Molecular classification of breast carcinoma: from traditional, old-fashioned way to a new age, and a new way N Eliyatkın, E Yalçın, B Zengel, S Aktaş, E Vardar The journal of breast health 11 (2), 59, 2015 | 396 | 2015 |
Demonstration of ventricular myocardial extensions into the pulmonary artery and aorta beyond the ventriculo‐arterial junction CAN Hasdemir, S Aktas, F Govsa, EO Aktas, A Kocak, YT Bozkaya, ... Pacing and Clinical Electrophysiology 30 (4), 534-539, 2007 | 160 | 2007 |
BRCA genes: BRCA 1 and BRCA 2. U Varol, Y Kucukzeybek, A Alacacioglu, I Somali, Z Altun, S Aktas, ... apoptosis 13, 19, 2018 | 109 | 2018 |
Evaluation of the Effect of Acetyl L-Carnitine on Experimental Cisplatin Nephrotoxicity O Tufekci, D Gunes, C Özoğul, E Kolatan, Z Altun, O Yılmaz, S Aktaş, ... Chemotherapy 55 (6), 451-459, 2009 | 65 | 2009 |
Protective effect of acetyl‐l‐carnitine against cisplatin ototoxicity: role of apoptosis‐related genes and pro‐inflammatory cytokines Z Altun, Y Olgun, P Ercetin, S Aktas, G Kirkim, B Serbetcioglu, N Olgun, ... Cell proliferation 47 (1), 72-80, 2014 | 59 | 2014 |
Evaluation of the effect of acetyl L-carnitine on experimental cisplatin ototoxicity and neurotoxicity D Gunes, G Kirkim, E Kolatan, EA Guneri, C Ozogul, Z Altun, ... Chemotherapy 57 (3), 186-194, 2011 | 55 | 2011 |
Sex determination from the sternal end of the rib by osteometric analysis A Koçak, EÖ Aktas, S Ertürk, S Aktas, A Yemisçigil Legal Medicine 5 (2), 100-104, 2003 | 54 | 2003 |
Protective Effects of Acetyl-l-Carnitine on Cisplatin Cytotoxicity and Oxidative Stress in Neuroblastoma ZS Altun, D Güneş, S Aktaş, Z Erbayrktar, N Olgun Neurochemical research 35, 437-443, 2010 | 50 | 2010 |
Analysis of genetic and non genetic risk factors for cisplatin ototoxicity in pediatric patients Y Olgun, S Aktaş, Z Altun, G Kırkım, DÇ Kızmazoğlu, AP Erçetin, B Demir, ... International journal of pediatric otorhinolaryngology 90, 64-69, 2016 | 45 | 2016 |
Friend or foe? Effect of oral resveratrol on cisplatin ototoxicity Y Olgun, G Kırkım, E Kolatan, M Kıray, A Bagrıyanık, A Olgun, ... The Laryngoscope 124 (3), 760-766, 2014 | 42 | 2014 |
Experience of the izmir pediatric oncology group on neuroblastoma: IPOG-NBL-92 protocol N Olgun, S Kansoy, S Aksoylar, N Cetingul, C Vergin, H Oniz, ... Pediatric hematology and oncology 20 (3), 211-218, 2003 | 38 | 2003 |
Is there a gender-related susceptibility for cisplatin ototoxicity? G Kirkim, Y Olgun, S Aktas, M Kiray, E Kolatan, Z Altun, P Erçetin, ... European Archives of Oto-Rhino-Laryngology 272, 2755-2763, 2015 | 37 | 2015 |
Expression profiling reveals MSX1 and EphB2 expression correlates with the invasion capacity of Wilms tumors A Chetcuti, S Aktas, N Mackie, C Ulger, G Toruner, M Alkan, D Catchpoole Pediatric blood & cancer 57 (6), 950-957, 2011 | 33 | 2011 |
Intercostal Variation for Age Estimation–Are the Standards for the Right 4th Rib Applicable for Other Ribs? E Özgür Aktas, A Koçak, S Aktas, A Yemisçigil Collegium antropologicum 28 (2), 267-272, 2004 | 33 | 2004 |
Expression of stromal caveolin-1 may be a predictor for aggressive behaviour of breast cancer N Eliyatkin, S Aktas, G Diniz, HH Ozgur, ZY Ekin, A Kupelioglu Pathology & Oncology Research 24, 59-65, 2018 | 31 | 2018 |
Tissue expression of MLH1, PMS2, MSH2, and MSH6 proteins and prognostic value of microsatellite instability in Wilms tumor: experience of 45 cases G Diniz, S Aktas, C Cubuk, R Ortac, C Vergin, N Olgun Pediatric Hematology and Oncology 30 (4), 273-284, 2013 | 30 | 2013 |
Antioxidant effect of acetyl-l-carnitine against cisplatin-induced cardiotoxicity S Bayrak, S Aktaş, Z Altun, Y Cakir, M Tütüncü, S Kum Özşengezer, ... Journal of International Medical Research 48 (8), 0300060520951393, 2020 | 29 | 2020 |
Tubular dysplasia and carcinoma in situ: precursors of renal cell carcinoma K Yörükoğlu, S Aktas, MU Mungan, Z Kirkali Urology 53 (4), 684-689, 1999 | 29 | 1999 |
Breast cancer risk in neurofibromatosis type 1 is a function of the type of NF1 gene mutation: a new genotype-phenotype correlation IM Frayling, VF Mautner, R Van Minkelen, RA Kallionpaa, S Aktaş, ... Journal of Medical Genetics 56 (4), 209-219, 2019 | 28 | 2019 |
Chaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma I Agababaoglu, A Önen, AB Demir, S Aktas, Z Altun, H Ersöz, A Sanl, ... Medicine 96 (6), e5903, 2017 | 26 | 2017 |